CD40 signaling and Alzheimer's disease pathogenesis
Authors:
- Jun TanJTJun Tan
- Michael MullanMMMichael Mullan
- 1 November 2001
- journal article
- review article
- Published by Elsevier in Neurochemistry International
- Vol. 39 (5-6) , 371-380
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- CD45 Inhibits CD40L-induced Microglial Activation via Negative Regulation of the Src/p44/42 MAPK PathwayJournal of Biological Chemistry, 2000
- The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivoJournal of Clinical Investigation, 2000
- Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activationEuropean Journal of Immunology, 1999
- One-way Cross-talk between p38MAPK and p42/44MAPKJournal of Biological Chemistry, 1999
- High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 1999
- Is the Ras-MAPK signalling pathway necessary for long-term memory formation?Trends in Neurosciences, 1999
- Amyloid‐β Protein Angiopathies Masquerading as Alzheimer's Disease?aAnnals of the New York Academy of Sciences, 1997
- Interleukin-18 Induces Activation and Association of p56lck and MAPK in a Murine TH1 CloneBiochemical and Biophysical Research Communications, 1997
- Immune Reactions Associated With Cerebral Amyloid AngiopathyStroke, 1996
- Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase mosNeurobiology of Aging, 1996